more...

>

Intellectual Property

>

Success and Statistics

>

Esperance Pharmaceuticals [Image: Image of Pills] Esperance Pharmaceuticals Inc. is a new Louisiana-based biopharmaceutical company that develops novel anticancer agents. Esperance uses patented technologies from the LSU AgCenter, Pennington Biomedical Research Center and Louisiana State University as a foundation for their revolutionary cancer treatments. Their newest drug, EP-100, is currently in Phase 2 clinical trials. April 24, 2008 First Louisiana Biotech Company Focused on Cancer Announces Opening October 5, 2009 New drug aims to 'seek and destroy' many types of cancer  May 17, 2012 Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane‐disrupting Agent, EP‐ 100, in Patients with Advanced Ovarian Cancer For more information on Esperance Pharmaceuticals visit: http://www.esperancepharma.com/

Last Updated: 10/24/2012 11:49:58 AM